Citalopram, a Selective Serotonin Reuptake Inhibitor, Improves Symptoms of Friedreich's Ataxia
Albert S. Rohr, K. Eichler, N. Hafezi-Moghadam
Abstract
Albert S. Rohr, K. Eichler, N. Hafezi-Moghadam
Abstract
Two patients (siblings) with Friedreich's ataxia showed improvement in their clinical symptoms--particularly spasticity and cardiac symptoms--after treatment with the selective serotonin reuptake inhibitor citalopram.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Two patients (siblings) with Friedreich's ataxia showed improvement in their clinical symptoms--particularly spasticity and cardiac symptoms--after treatment with the selective serotonin reuptake inhibitor citalopram.
Key concepts: Citalopram, Serotonin reuptake inhibitor, Ataxia, Reuptake inhibitor, Serotonin Uptake Inhibitors, Fluoxetine, Serotonin, Medicine